MedPath

Ampicillin

Ampicillin for Injection, USP

Approved
Approval ID

bbf118c0-7cd3-5a82-e053-2a95a90ac8c8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 8, 2023

Manufacturers
FDA

Medical Purchasing Solutions, LLC

DUNS: 601458529

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ampicillin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71872-7240
Application NumberANDA062772
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ampicillin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMay 8, 2023
FDA Product Classification

INGREDIENTS (1)

AMPICILLIN SODIUMActive
Quantity: 2 g in 1 1
Code: JFN36L5S8K
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ampicillin - FDA Drug Approval Details